Usefulness of the convexity apparent hyperperfusion sign in 123I-iodoamphetamine brain perfusion SPECT for the diagnosis of idiopathic normal pressure hydrocephalus.
Aged
Aged, 80 and over
Amphetamines
Brain
/ diagnostic imaging
Cerebrovascular Circulation
Cognition
Female
Gray Matter
/ blood supply
Humans
Hydrocephalus, Normal Pressure
/ diagnostic imaging
Magnetic Resonance Imaging
Male
Mental Status and Dementia Tests
Middle Aged
Perfusion
Radiopharmaceuticals
Reproducibility of Results
Retrospective Studies
Tomography, Emission-Computed, Single-Photon
/ methods
123I-IMP = 123I-iodoamphetamine
123I-IMP SPECT
ARG = autoradiography
CAP = patients with the CAPPAH sign
CAPPAH = convexity apparent hyperperfusion
CBF = cerebral blood flow
DESH = disproportionately enlarged subarachnoid space hydrocephalus
FAB = Frontal Assessment Battery
MMSE = Mini–Mental State Examination
NCAP = patients without the CAPPAH sign
ROI = region of interest
SEE = stereotactic extraction estimation
SSP = stereotactic surface projection
TMT-A = Trail Making Test A
TUG = Timed Up and Go
cerebral blood flow
convexity apparent hyperperfusion sign
iNPH = idiopathic normal pressure hydrocephalus
iNPHGS = iNPH Grading Scale
idiopathic normal pressure hydrocephalus
rCBF = regional CBF
Journal
Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
03
05
2017
accepted:
25
09
2017
pubmed:
17
3
2018
medline:
19
10
2019
entrez:
17
3
2018
Statut:
ppublish
Résumé
The gold standard for the diagnosis of idiopathic normal pressure hydrocephalus (iNPH) is the CSF
removal test. For elderly patients, however, a less invasive diagnostic method is required. On MRI, high-convexity tightness was reported to be an important finding for the diagnosis of iNPH. On SPECT, patients with iNPH often show hyperperfusion of the high-convexity area. The authors tested 2 hypotheses regarding the SPECT finding: 1) it is relative hyperperfusion reflecting the increased gray matter density of the convexity, and 2) it is useful for the diagnosis of iNPH. The authors termed the SPECT finding the convexity apparent hyperperfusion (CAPPAH) sign. Two clinical studies were conducted. In study 1, SPECT was performed for 20 patients suspected of having
iNPH, and regional cerebral blood flow (rCBF) of the high-convexity area was examined using quantitative analysis. Clinical differences between patients with the CAPPAH sign (CAP) and those without it (NCAP) were also compared. In study 2, the CAPPAH sign was retrospectively assessed in 30 patients with iNPH and 19 healthy controls using SPECT images and 3D stereotactic surface projection. In study 1, rCBF of the high-convexity area of the CAP group was calculated as 35.2–43.7 ml/min/100 g,
which is not higher than normal values of rCBF determined by SPECT. The NCAP group showed lower cognitive function and weaker responses to the removal of CSF than the CAP group. In study 2, the CAPPAH sign was positive only in patients with iNPH (24/30) and not in controls (sensitivity 80%, specificity 100%). The coincidence rate between tight high convexity on MRI and the CAPPAH sign was very high (28/30). Patients with iNPH showed hyperperfusion of the high-convexity area on SPECT; however, the presence of the CAPPAH sign did not indicate real hyperperfusion of rCBF in the high-convexity area. The authors speculated that patients with iNPH without the CAPPAH sign, despite showing tight high convexity on MRI, might have comorbidities such as Alzheimer’s disease.
Identifiants
pubmed: 29547088
doi: 10.3171/2017.9.JNS171100
doi:
Substances chimiques
Amphetamines
0
Radiopharmaceuticals
0
4-iodoamphetamine
21894-72-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM